Eksterne analyser

Administer: Behind the curve, earnings to recover - Evli

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier

Administer's Q1 missed our estimates, with Silta and EmCe driving the sales shortfall and cost savings yet to fully offset lower volumes on profitability. FY26 guidance and management commentary signal an H2-led recovery.